• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Present to future: what the reasons for declining first-trimester combined testing tell us about accepting or declining cell-free DNA testing.

作者信息

Crombag Neeltje M T H, van Schendel Rachel V, Schielen Peter C J I, Bensing Jozien M, Henneman Lidewij

机构信息

Department of Obstetrics, University Medical Center Utrecht, Utrecht, The Netherlands.

Department of Clinical Genetics, section Community Genetics and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands.

出版信息

Prenat Diagn. 2016 Jun;36(6):587-90. doi: 10.1002/pd.4824. Epub 2016 May 10.

DOI:10.1002/pd.4824
PMID:27061402
Abstract
摘要

相似文献

1
Present to future: what the reasons for declining first-trimester combined testing tell us about accepting or declining cell-free DNA testing.从现在到未来：孕早期联合检测使用率下降的原因对无细胞DNA检测接受与否的启示
Prenat Diagn. 2016 Jun;36(6):587-90. doi: 10.1002/pd.4824. Epub 2016 May 10.
2
Reasons for accepting or declining Down syndrome screening in Dutch prospective mothers within the context of national policy and healthcare system characteristics: a qualitative study.在国家政策和医疗保健系统特征背景下，荷兰准母亲接受或拒绝唐氏综合征筛查的原因：一项定性研究
BMC Pregnancy Childbirth. 2016 May 26;16(1):121. doi: 10.1186/s12884-016-0910-3.
3
Decision analysis of prenatal testing for chromosomal disorders: what do the preferences of pregnant women tell us?染色体疾病产前检测的决策分析：孕妇的偏好能告诉我们什么？
Genet Test. 2001 Spring;5(1):23-32. doi: 10.1089/109065701750168644.
4
Women's views and the impact of noninvasive prenatal testing on procedures in a managed care setting.女性的观点以及无创产前检测对管理式医疗环境中医疗程序的影响。
Prenat Diagn. 2015 May;35(5):428-33. doi: 10.1002/pd.4495. Epub 2014 Sep 30.
5
NIPT-based screening for Down syndrome and beyond: what do pregnant women think?基于无创产前检测（NIPT）的唐氏综合征及其他疾病筛查：孕妇怎么看？
Prenat Diagn. 2015 Jun;35(6):598-604. doi: 10.1002/pd.4579. Epub 2015 Mar 30.
6
[Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].游离胎儿DNA在母体血浆中用于无创产前诊断的临床应用
Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):813-7.
7
Cell-free fetal DNA: the new tool in fetal medicine.游离胎儿DNA：胎儿医学的新工具。
Ultrasound Obstet Gynecol. 2015 May;45(5):499-507. doi: 10.1002/uog.14746.
8
Characteristics of first-trimester screening of non-responders in a high-uptake population.高接受率人群中无反应者的孕早期筛查特征
Dan Med J. 2016 Apr;63(4).
9
Impact of first-trimester aneuploidy screening in a high-risk population.孕早期非整倍体筛查在高危人群中的影响。
Fetal Diagn Ther. 2009;26(1):29-34. doi: 10.1159/000236356. Epub 2009 Oct 10.
10
Has noninvasive fetal trisomy testing (NIFTY) rung the death knell for other forms of prenatal testing?无创胎儿三体检测（NIFTY）是否敲响了其他形式产前检测的丧钟？
Fertil Steril. 2014 Jul;102(1):34-5. doi: 10.1016/j.fertnstert.2014.05.016. Epub 2014 Jun 2.

引用本文的文献

1
Factors influencing pregnant women's decision to accept or decline prenatal screening and diagnosis - a qualitative study.影响孕妇接受或拒绝产前筛查与诊断决定的因素——一项定性研究
J Community Genet. 2024 Dec;15(6):711-721. doi: 10.1007/s12687-024-00746-3. Epub 2024 Nov 1.
2
Prenatal screening tests and prevalence of fetal aneuploidies in a tertiary hospital in Thailand.泰国一家三级医院的产前筛查检测与胎儿非整倍体的流行率。
PLoS One. 2023 Apr 20;18(4):e0284829. doi: 10.1371/journal.pone.0284829. eCollection 2023.
3
Uptake of fetal aneuploidy screening after the introduction of the non-invasive prenatal test: A national population-based register study.
非侵入性产前检测引入后胎儿非整倍体筛查的应用：一项全国基于人群的登记研究。
Acta Obstet Gynecol Scand. 2021 Jul;100(7):1265-1272. doi: 10.1111/aogs.14091. Epub 2021 Feb 9.
4
Facilitating informed choice about non-invasive prenatal testing (NIPT): a systematic review and qualitative meta-synthesis of women's experiences.促进非侵入性产前检测（NIPT）知情选择：对女性体验的系统评价和定性元分析。
BMC Pregnancy Childbirth. 2019 Jan 14;19(1):27. doi: 10.1186/s12884-018-2168-4.
5
Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals.非侵入性产前检测（NIPT）的范围限制：对产前筛查国际伦理框架的分析及对荷兰专业人士的访谈研究。
BMC Pregnancy Childbirth. 2018 Oct 19;18(1):409. doi: 10.1186/s12884-018-2050-4.
6
A Framework for Describing the Influence of Service Organisation and Delivery on Participation in Fetal Anomaly Screening in England.描述服务组织与提供对英格兰胎儿异常筛查参与情况影响的框架
J Pregnancy. 2017;2017:4975091. doi: 10.1155/2017/4975091. Epub 2017 Mar 22.
7
The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy population.在一般妊娠人群中，初级产科保健提供者进行基于 DNA 的胎儿非整倍体筛查的临床实用性。
Genet Med. 2017 Jul;19(7):778-786. doi: 10.1038/gim.2016.194. Epub 2017 Jan 12.